SEARCH

SEARCH BY CITATION

References

  • 1
    American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th edition. Glenview, IL: American Pain Society; 2003.
  • 2
    Gordon DB, Dahl JL, Miaskowski C, et al. American Pain Society recommendations for improving the quality of acute and cancer Pain management. Arch Intern Med 2005;165:157480.
  • 3
    Miaskowski C, Cleary J, Burney R, et al. Guideline for the Management of Cancer Pain in Adults and Children. APS Clinical Practice Guidelines Series, No. 3. Glenview, IL: American Pain Society; 2005.
  • 4
    World Health Organization. Cancer Pain Relief: With a Guide to Opioid Availability, 2nd edition. Geneva, Switzerland: World Health Organization; 1996.
  • 5
    Ballantyne JC. Opioids for chronic pain: Taking stock. Pain 2006;125:34.
  • 6
    Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy for chronic noncancer pain. J Pain 2007;10:130.
  • 7
    Fine PG, Portenoy RK. A Clinical Guide to Opioid Analgesia, 2nd edition. New York: Vendome Group, LLC; 2007.
  • 8
    Kalso E, Edwards JE, Moore A, McQuay H. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004;112:37280.
  • 9
    Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:194353.
  • 10
    Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: An epidemiological study. Pain 2006;125:1729.
  • 11
    Fields HL. Should we be reluctant to prescribe opioids for chronic non-malignant pain? Pain 2007;129:2334.
  • 12
    Boulanger A, Clark AJ, Squire P, Cui E, Horbay GLA. Chronic pain in Canada: Have we improved management of chronic noncancer pain? Pain Res Manag 2007;12:3947.
  • 13
    Gilson AM, Joranson DE. Controlled substances and pain management: Changes in knowledge and attitudes of state medical regulators. J Pain Symptom Manage 2001;21:22737.
  • 14
    Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment. J Pain 2007;8:68291.
  • 15
    Weinstein SM, Laux LF, Thornby JI, et al. Physicians' attitudes toward pain and the use of opioid analgesics: Results of a survey from the Texas Cancer Pain Initiative. South Med J 2000;93:47987.
  • 16
    Wells M, Dryden H, Guild P, et al. The knowledge and attitudes of surgical staff towards the use of opioids in cancer pain management: Can the Hospital Palliative Care Team make a difference? Eur J Cancer Care 2001;10:20111.
  • 17
    Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med 2006;21:6525.
  • 18
    Savage SR, Joranson DE, Covington EC, et al. Definitions related to the medical use of opioids: Evolution towards universal agreement. J Pain Symptom Manage 2003;26:65567.
  • 19
    Dahl JL. Working with regulators to improve the standard of care in pain management: The U.S. experience. J Pain Symptom Manage 2002;24:13646.
  • 20
    Gallagher R. Opioids in chronic pain management: Navigating the clinical and regulatory challenges. J Fam Pract Suppl 2004;53:S23S32.
  • 21
    Quill TE, Meier DE. The big chill-inserting the DEA into end-of-life care. N Engl J Med 2006;354:13.
  • 22
    Ziegler SJ, Lovrich NP. Pain relief, prescription drugs, and prosecution: A four-state survey of chief prosecutors. J Law Med Ethics 2003;31:75100.
  • 23
    Mantyselka P, Kumpusalo E, Ahonen R, Takala J. Patients' versus general practitioners' assessments of pain intensity in primary care patients with non-cancer pain. Br J Gen Pract 2001;51:9957.
  • 24
    Harris JMJ, Fulginiti JV, Gordon PR, et al. KnowPain-50: A tool for assessing physician pain management education. Pain Med 2008;9:54254.
  • 25
    Institute of Medicine Committee on Care at the End of Life. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997.
  • 26
    Joranson DE, Gilson AM. Wanted: A public health approach to prescription opioid abuse and diversion (Editorial). Pharmacoepidemiol Drug Saf 2006;15:6324.
  • 27
    Weissman DE, Joranson DE, Hopwood MB. Wisconsin physicians' knowledge and attitudes about opioid analgesic regulations. Wis Med J 19916715.
  • 28
    Dahl JL. State cancer pain initiatives. J Pain Symptom Manage 1993;8:3725.
  • 29
    Dahl JL, Bennett ME, Bromley MD, Joranson DE. Success of the state pain initiatives. Cancer Pract 2002;10:S9S13.
  • 30
    Weissman DE, Dahl JL, Beasley JW. The cancer pain role model program of the Wisconsin Cancer Pain Initiative. J Pain Symptom Manage 1993;8:2935.
  • 31
    Weissman DE, Griffie J, Gordon DB, Dahl JL. A role model program to promote institutional changes for management of acute and cancer pain. J Pain Symptom Manage 1997;14:2749.
  • 32
    Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28:2508.
  • 33
    Rich BA. An ethical analysis of the barriers to effective pain management. Camb Q Healthc Ethics 2000;9:5470.
  • 34
    Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:304352.
  • 35
    Furlan AD, Sandoval JA, Mallis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. Can Med Assoc J 2006;174:158994.
  • 36
    Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006;6:4655.
  • 37
    Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain 2002;18:S91S98.
  • 38
    Blake S, Ruel B, Seamark C, Seamark D. Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: A patient-initiated study. Br J Gen Pract 2007;57:1018.
  • 39
    Joranson DE, Gilson AM. Drug crime is a source of abused pain medications in the United States [letter. J Pain Symptom Manage 2005;30:299301.
  • 40
    Code of Federal Regulations. Title 21 CFR §1306.04(a). 2003.
  • 41
    United States of America Congressional Record. Proceedings and Debates of the 91st Congress Second Session, Volume 116—Part 25. Washington, DC: United States Government Printing Office; 1970.
  • 42
    Joranson DE, Cleeland CS, Weissman DE, Gilson AM. Opioids for chronic cancer and non-cancer pain: A survey of state medical board members. Fed Bull J Med Licen Disc 1992;79:1549.
  • 43
    Wisconsin Medical Society. State Medical Society of Wisconsin statement of the use of opioids for the treatment of chronic pain. Wis Med J 2001;100:225.
  • 44
    Wisconsin Medical Society Task Force on Pain Management. Guidelines for the assessment and management of chronic pain. Wis Med J 2004;103:1542.
  • 45
    Wisconsin Medical Examining Board. Position statement on pain management. 3-14-2007.